Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

RXRX has reported updated data from its ELUCIDATE and TUPELO trials, but the stock has failed to mount a sustained rally. The ELUCIDATE update provides just an additional 10 patients of data treated ...

With a single click, unlock detailed, AI-assisted insights pulled from hundreds of financial data points instantly. News headlines Recursion Pharmaceuticals (RXRX) is navigating a challenging ...

We list the best IDE for Python, to make it simple and easy for programmers to manage their Python code with a selection of specialist tools. An Integrated Development Environment (IDE) allows you to ...

Their perilous situation is attributed primarily to the over-harvesting of their eggs during the last century. And though their nesting grounds are protected and many commercial fishing fleets now use ...

Finding the right book can make a big difference, especially when you’re just starting out or trying to get better. We’ve ...